Advanced Proteome Therapeutics Stock Analysis
| APTCF Stock | USD 0.0002 0.00 0.00% |
Advanced Proteome Therapeutics is overvalued with Real Value of 1.68E-4 and Hype Value of 2.0E-4. The main objective of Advanced Proteome pink sheet analysis is to determine its intrinsic value, which is an estimate of what Advanced Proteome Therapeutics is worth, separate from its market price. There are two main types of Advanced Proteome's stock analysis: fundamental analysis and technical analysis.
The Advanced Proteome pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Advanced Proteome's ongoing operational relationships across important fundamental and technical indicators.
Advanced |
Advanced Pink Sheet Analysis Notes
The book value of the company was presently reported as 0.02. The company last dividend was issued on the 8th of May 2019. Advanced Proteome had 1:10 split on the 8th of May 2019. Advanced Proteome Therapeutics Corporation, through its subsidiary, Advanced Proteome Therapeutics Inc., operates as a biotechnology company in the United States. Its platform is dedicated to applications in the field of antibody drug conjugates, as well as focused on protein conjugates and immunomodulation. Advanced Proteome operates under Biotechnology classification in the United States and is traded on OTC Exchange.The quote for Advanced Proteome Therapeutics is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Advanced Proteome Therapeutics please contact Paul Woodward at 604-690-3797 or go to https://www.advancedproteome.com.Advanced Proteome Investment Alerts
| Advanced Proteome generated a negative expected return over the last 90 days | |
| Advanced Proteome has some characteristics of a very speculative penny stock | |
| Advanced Proteome Therapeutics has accumulated 227.41 K in total debt with debt to equity ratio (D/E) of 4.65, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Advanced Proteome has a current ratio of 0.54, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Advanced Proteome until it has trouble settling it off, either with new capital or with free cash flow. So, Advanced Proteome's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Advanced Proteome sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Advanced to invest in growth at high rates of return. When we think about Advanced Proteome's use of debt, we should always consider it together with cash and equity. | |
| Advanced Proteome Therapeutics has accumulated about 761.6 K in cash with (693.58 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Advanced Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.47 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Advanced Proteome's market, we take the total number of its shares issued and multiply it by Advanced Proteome's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
Advanced Proteome technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Advanced Proteome Price Movement Analysis
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Advanced Proteome middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Advanced Proteome. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
About Advanced Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Advanced Proteome prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Advanced shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Advanced Proteome. By using and applying Advanced Pink Sheet analysis, traders can create a robust methodology for identifying Advanced entry and exit points for their positions.
Advanced Proteome Therapeutics Corporation, through its subsidiary, Advanced Proteome Therapeutics Inc., operates as a biotechnology company in the United States. Its platform is dedicated to applications in the field of antibody drug conjugates, as well as focused on protein conjugates and immunomodulation. Advanced Proteome operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Advanced Proteome to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Price Ceiling Movement Now
Price Ceiling MovementCalculate and plot Price Ceiling Movement for different equity instruments |
| All Next | Launch Module |
Complementary Tools for Advanced Pink Sheet analysis
When running Advanced Proteome's price analysis, check to measure Advanced Proteome's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Advanced Proteome is operating at the current time. Most of Advanced Proteome's value examination focuses on studying past and present price action to predict the probability of Advanced Proteome's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Advanced Proteome's price. Additionally, you may evaluate how the addition of Advanced Proteome to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |